Fjarde AP Fonden Fourth Swedish National Pension Fund Has $3.35 Million Stake in Healthpeak Properties, Inc. $DOC

Fjarde AP Fonden Fourth Swedish National Pension Fund increased its position in Healthpeak Properties, Inc. (NYSE:DOC) by 101.7% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 203,700 shares of the real estate investment trust’s stock after purchasing an additional 102,700 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Healthpeak Properties were worth $3,347,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Fiduciary Trust Co raised its holdings in Healthpeak Properties by 4.9% during the third quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust’s stock worth $264,000 after buying an additional 644 shares during the last quarter. Patton Fund Management Inc. raised its holdings in shares of Healthpeak Properties by 5.2% in the 4th quarter. Patton Fund Management Inc. now owns 13,002 shares of the real estate investment trust’s stock worth $209,000 after acquiring an additional 648 shares during the last quarter. Quadrant Capital Group LLC lifted its position in Healthpeak Properties by 1.9% in the 3rd quarter. Quadrant Capital Group LLC now owns 37,650 shares of the real estate investment trust’s stock valued at $721,000 after acquiring an additional 718 shares in the last quarter. Intrua Financial LLC boosted its stake in Healthpeak Properties by 1.1% during the 1st quarter. Intrua Financial LLC now owns 66,702 shares of the real estate investment trust’s stock valued at $1,096,000 after purchasing an additional 744 shares during the last quarter. Finally, New Mexico Educational Retirement Board boosted its stake in Healthpeak Properties by 2.5% during the 4th quarter. New Mexico Educational Retirement Board now owns 32,200 shares of the real estate investment trust’s stock valued at $518,000 after purchasing an additional 800 shares during the last quarter. Institutional investors and hedge funds own 93.57% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently commented on DOC. BMO Capital Markets increased their price objective on Healthpeak Properties from $20.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, June 15th. JPMorgan Chase & Co. increased their price target on Healthpeak Properties from $18.00 to $21.00 and gave the company a “neutral” rating in a research report on Wednesday, June 24th. Morgan Stanley reaffirmed an “equal weight” rating and set a $22.00 price objective (up from $20.00) on shares of Healthpeak Properties in a report on Thursday, June 11th. Barclays began coverage on shares of Healthpeak Properties in a research note on Tuesday. They issued an “equal weight” rating and a $23.00 target price for the company. Finally, Raymond James Financial initiated coverage on shares of Healthpeak Properties in a report on Wednesday, June 17th. They issued a “market perform” rating for the company. Four equities research analysts have rated the stock with a Buy rating and fifteen have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $20.35.

Healthpeak Properties Price Performance

Shares of NYSE DOC opened at $21.75 on Tuesday. The company has a market capitalization of $14.99 billion, a PE ratio of 67.97, a PEG ratio of 3.41 and a beta of 1.02. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15. The stock’s 50 day moving average price is $19.65 and its 200-day moving average price is $17.89. Healthpeak Properties, Inc. has a twelve month low of $15.70 and a twelve month high of $22.04.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The business had revenue of $752.95 million for the quarter, compared to analyst estimates of $694.59 million. During the same period last year, the company posted $0.46 earnings per share. Healthpeak Properties’s quarterly revenue was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. On average, equities analysts anticipate that Healthpeak Properties, Inc. will post 1.75 EPS for the current year.

Insider Activity

In other news, insider Scott R. Bohn sold 10,989 shares of the firm’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the completion of the sale, the insider directly owned 7,636 shares of the company’s stock, valued at $148,520.20. This trade represents a 59.00% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 0.23% of the stock is currently owned by corporate insiders.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.